Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease.
about
Loss of Ypk1, the yeast homolog to the human serum- and glucocorticoid-induced protein kinase, accelerates phospholipase B1-mediated phosphatidylcholine deacylationAssociation of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's diseaseGene expression and functional annotation of the human and mouse choroid plexus epithelium.Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's diseaseAge-dependent biochemical dysfunction in skeletal muscle of triple-transgenic mouse model of Alzheimer`s disease.Dopaminergic Neurons Respond to Iron-Induced Oxidative Stress by Modulating Lipid Acylation and Deacylation Cycles.Combined Sepiapterin Reductase and Methylmalonyl-CoA Epimerase Deficiency in a Second Patient: Cerebrospinal Fluid Polyunsaturated Fatty Acid Level and Follow-Up Under L-DOPA, 5-HTP and BH4 Trials.Annotation of the human cerebrospinal fluid lipidome using high resolution mass spectrometry and a dedicated data processing workflow.ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease.Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study.Quantitative analysis of N-acylphosphatidylethanolamine molecular species in rat brain using solid-phase extraction combined with reversed-phase chromatography and tandem mass spectrometryIntegration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samplesLipidomic analysis of cerebrospinal fluid by mass spectrometry-based methods.Recent advances in lipidomics for disease research.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.Amniotic fluid levels of phospholipase A2 in fetal rats with retinoic acid induced myelomeningocele: the potential "second hit" in neurologic damage.Embedded in the Membrane: How Lipids Confer Activity and Specificity to Intramembrane Proteases.Arachidonic or Docosahexaenoic Acid Diet Prevents Memory Impairment in Tg2576 Mice.Plasma lipids metabolism in mild cognitive impairment and Alzheimer's disease.
P2860
Q27930785-F2668503-B34D-4E38-A5D8-405CD1BDCB66Q30238885-12C12D3F-F7FA-4E99-AF17-031AEBF23143Q33793583-0DFEAC9B-BA37-4ACB-9F50-DF1876EA5081Q35082443-D565205D-5504-4CF0-86DC-7EC258F06659Q35566575-DA21219C-5883-423F-90E3-DF584ABD5898Q35596754-FEF87643-3E7D-4417-89D2-0C3715216F5CQ35664174-84C3191C-2916-41D6-A032-3F8B56E68E81Q35801014-9C873A80-88E3-404B-84DA-8DAE59C497E8Q35997902-8E9B86DF-1905-417D-8303-BC7BD026F5D2Q36713957-44720234-4FCB-4C38-8BA1-49A693FDB681Q37091714-0B6027AB-C8B0-4569-BE0C-14F8FE7D215FQ37105737-A5058101-9A18-4586-B3C9-8F1347E9FFC6Q37131903-EC28A7E4-6293-4195-8824-6A38BFE78198Q38285578-9C0D8B3F-46EC-43AC-9205-8B7251377597Q38591116-09783A0F-042B-448E-813E-29E0F79CAF01Q38805367-7B349B4E-2F18-454D-964E-A414738B6B3CQ45220745-0A557A8D-6353-4496-923A-0109BED810FDQ47232868-F4FE90CB-4F9E-48CF-8895-F8BC6576DCDDQ47641650-36B4458C-DAAC-41AE-851E-6893BF2F4E5DQ50041775-A8EE9CFE-E4DE-4EA0-9979-61E3F943C2C6
P2860
Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alterations in cerebrospinal f ...... tivity in Alzheimer's disease.
@en
Alterations in cerebrospinal f ...... tivity in Alzheimer's disease.
@nl
type
label
Alterations in cerebrospinal f ...... tivity in Alzheimer's disease.
@en
Alterations in cerebrospinal f ...... tivity in Alzheimer's disease.
@nl
prefLabel
Alterations in cerebrospinal f ...... tivity in Alzheimer's disease.
@en
Alterations in cerebrospinal f ...... tivity in Alzheimer's disease.
@nl
P2093
P2860
P921
P356
P1476
Alterations in cerebrospinal f ...... ctivity in Alzheimer's disease
@en
P2093
Alejandra Chirino
Alfred N Fonteh
Fatimatou Diallo
Jiarong Chiang
Matthew Cipolla
Xianghong Arakaki
P2860
P304
P356
10.1194/JLR.M037622
P577
2013-07-18T00:00:00Z